Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
425 studies found for:    "Idiopathic pulmonary hypertension"
Show Display Options
Rank Status Study
21 Completed
Has Results
Pilot Chart Review Study Of Sitaxentan Sodium (Thelin) In Patients With Pulmonary Arterial Hypertension (PAH)
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Sitaxentan sodium
22 Recruiting REPAIR: Right vEntricular Remodeling in Pulmonary ArterIal hypeRtension
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Macitentan
23 Completed
Has Results
Evaluate The Clinical Effectiveness, Safety And Tolerability Of Sildenafil Used In Doses ≥20mg TID For The Treatment Of Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: sildenafil citrate
24 Active, not recruiting Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Macitentan
25 Terminated
Has Results
Extension to CQTI571A2102 to Evaluate Long-term Safety, Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension (PAH)
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Imatinib
26 Active, not recruiting Clinical Study to Assess the Long-term Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Macitentan
27 Temporarily not available Open Label Access Study Of Sildenafil In Adult Patients With Pulmonary Arterial Hypertension Completing A1481244 Study
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Sildenafil citrate
28 Recruiting Aerobic Exercise Training in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Other: Upper extremity aerobic exercise training;   Other: Alternative upper extremity exercises
29 Completed
Has Results
Iloprost Power 15 in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: iloprost (5 µg);   Drug: placebo
30 Completed Bosentan in Children With Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Bosentan
31 Completed Bosentan in Children With Pulmonary Arterial Hypertension Extension Study
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Bosentan
32 Active, not recruiting Pharmacokinetic Study of Sub-q and IV Treprostinil in Kids With Pulmonary Arterial Hypertension (PAH)
Condition: Pulmonary Arterial Hypertension
Intervention:
33 Completed Effects of Two Dosing Regimens of Bosentan in Children With Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: bosentan
34 Terminated
Has Results
Efficacy, Safety, Tolerability and Pharmacokinetics (PK) of Nilotinib (AMN107) in Pulmonary Arterial Hypertension (PAH)
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Nilotinib;   Drug: Placebo to nilotinib
35 Completed Responsiveness of Exercise Tests in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Sildenafil;   Drug: Sugar Pill
36 Withdrawn Beta Blockers for Treatment of Pulmonary Arterial Hypertension in Children
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Carvedilol
37 Completed
Has Results
Imatinib (QTI571) in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: imatinib mesylate;   Drug: Placebo
38 Completed
Has Results
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: iloprost
39 Terminated Long-term Study of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension Who Completed AIR001-CS05
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: AIR001
40 Terminated A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: AIR001 (sodium nitrite inhalation solution)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.